Zobrazeno 1 - 10
of 339
pro vyhledávání: '"Robert A. Cowan"'
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 15 (2024)
Background: Currently, there are no biomarkers for migraine. Objectives: We aimed to identify proteomic biomarker signatures for diagnosing, subclassifying, and predicting treatment response in migraine. Design: This is a cross-sectional and longitud
Externí odkaz:
https://doaj.org/article/b0e651ab43e64110bbaf6d0db55ad50d
Autor:
Vimala N. Bharadwaj, Michael Klukinov, Robert Paul Cowan, Nazanin Mahinparvar, David John Clark, David Clifford Yeomans
Publikováno v:
Pharmaceutics, Vol 16, Iss 6, p 760 (2024)
Objective: Following a mild traumatic brain injury (mTBI), the most prevalent and profoundly debilitating occurrence is the emergence of an acute and persistent post-traumatic headache (PTH), for which there are presently no approved treatments. A cr
Externí odkaz:
https://doaj.org/article/748114f83ff9404b8cd0d07348318b64
Autor:
Robert P. Cowan, Michael J. Marmura, Hans-Christoph Diener, Amaal J. Starling, Jack Schim, Joe Hirman, Thomas Brevig, Roger Cady
Publikováno v:
The Journal of Headache and Pain, Vol 23, Iss 1, Pp 1-11 (2022)
Abstract Background Patients with chronic migraine (CM) treated with eptinezumab in the PROMISE-2 trial achieved greater reductions in migraine and headache frequency, impact, and acute headache medication (AHM) use than did patients who received pla
Externí odkaz:
https://doaj.org/article/bd0f0c2d765d4ba7964198b8fe92acdc
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract To survey persons with migraine who use social media about Complementary and Integrative Medicine (CIM) for the treatment of migraine. Background CIM encompasses medical treatments that are not part of but are used in concert with mainstream
Externí odkaz:
https://doaj.org/article/904bb69128e74abeb59f3fcf1b79e0fa
Autor:
Dawn C. Buse, Sanjay K. Gandhi, Joshua M. Cohen, Verena Ramirez-Campos, Blaine Cloud, Ronghua Yang, Robert P. Cowan
Publikováno v:
The Journal of Headache and Pain, Vol 21, Iss 1, Pp 1-11 (2020)
Abstract Background The long-term safety and efficacy of fremanezumab were evaluated in a 52-week extension study (NCT02638103). Patient satisfaction with fremanezumab, dosing preferences, and patient-reported outcomes were assessed in a subpopulatio
Externí odkaz:
https://doaj.org/article/8464cea9ead14f2fb27123c5dc3e888b
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 13 (2022)
Background: Computerized migraine diagnostic tools have been developed and validated since 1960. We conducted a systematic review to summarize and critically appraise the quality of all published studies involving computerized migraine diagnostic too
Externí odkaz:
https://doaj.org/article/606b8b08757e4bb08d27cfbbce04978e
Autor:
Katherine Castor, Jessica Dawlaty, Xianghong Arakaki, Noah Gross, Yohannes W. Woldeamanuel, Michael G. Harrington, Robert P. Cowan, Alfred N. Fonteh
Publikováno v:
Frontiers in Molecular Neuroscience, Vol 14 (2021)
BackgroundLipids are a primary storage form of energy and the source of inflammatory and pain signaling molecules, yet knowledge of their importance in chronic migraine (CM) pathology is incomplete. We aim to determine if plasma and cerebrospinal flu
Externí odkaz:
https://doaj.org/article/bacdda3e08a148bdb63bd2f80e7a903d
Autor:
Alan M. Rapoport, Jo H. Bonner, Tamar Lin, Dagan Harris, Yaron Gruper, Alon Ironi, Robert P. Cowan
Publikováno v:
The Journal of Headache and Pain, Vol 20, Iss 1, Pp 1-7 (2019)
Abstract Background There is a significant unmet need for new, effective and well tolerated acute migraine treatments. A recent study has demonstrated that a novel remote electrical neuromodulation (REN) treatment provides superior clinically meaning
Externí odkaz:
https://doaj.org/article/e4e85e28e0f04909a5613bb276a60e4f
Autor:
Stewart J. Tepper, Liron Rabany, Robert P. Cowan, Timothy R. Smith, Brian M. Grosberg, Bradley D. Torphy, Dagan Harris, Maya Vizel, Alon Ironi, Alit Stark‐Inbar, Andrew M. Blumenfeld
Publikováno v:
Headache: The Journal of Head and Face Pain. 63:377-389
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31e26cb152c8c96c11b6c6dff955d2aa
https://doi.org/10.1111/head.14469
https://doi.org/10.1111/head.14469
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 11 (2020)
Aims: The aims of this study were to: (a) identify differences in serum and cerebrospinal fluid (CSF) glucocorticoids among episodic migraine (EM) and chronic migraine (CM) patients compared with controls; (b) determine longitudinal changes in serum
Externí odkaz:
https://doaj.org/article/a04d144fdce740f8adcac3de1fc9a8d4